Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bilateral DLPC tDCS in Drug-resistant Migraine
NCT06079801Completed
- Sponsor
- Clínica de Intervención en Neurociencias
- Start
- Oct 2021
- Primary completion
- Apr 2023
- Countries
- 1
01
Overview
Randomised, double-blind trial in migraine, sponsored by Clínica de Intervención en Neurociencias. Primary endpoints: Migraine attacks monthly frequency at 6 months and Headache Impact Test at 6 months. Started Oct 2021; status: completed.
02
Conditions
migraine
Beyond the preview
Go deeper on NCT06079801.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06079801.